Morphosys AG(MOR)

18.96+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- MorphoSys任命诺华高管为新任CEO和CFO
  财通社 · 06-07
  MorphoSys任命诺华高管为新任CEO和CFO
- SK海力士计划在第6代（1c工艺约10nm）DRAM的生产中使用Inpria下一代金属氧化物光刻胶（MOR），这是MOR首次应用于DRAM量产工艺。
  华尔街见闻 · 05-30
  SK海力士计划在第6代（1c工艺约10nm）DRAM的生产中使用Inpria下一代金属氧化物光刻胶（MOR），这是MOR首次应用于DRAM量产工艺。
- 消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶
  IT之家 · 05-30
  消息称SK海力士将在1c DRAM生产中采用新型Inpria MOR光刻胶
- 【AI 开源激励网络 Morpheus 推出代币 MOR】5月8日消息，Wormhole 宣布 AI 开源激励网络 Morpheus 通过 Wormhole 的原生代币转移（NTT）框架推出多链代币 MOR，该代币将奖励共同构建、维护和利用开源去中心化人工智能基础设施的贡献者。
  金色财经 · 05-08
  【AI 开源激励网络 Morpheus 推出代币 MOR】5月8日消息，Wormhole 宣布 AI 开源激励网络 Morpheus 通过 Wormhole 的原生代币转移（NTT）框架推出多链代币 MOR，该代币将奖励共同构建、维护和利用开源去中心化人工智能基础设施的贡献者。
- Morphosys2024财年第一财季实现净利润-3.38亿美元，同比减少609.04%
  自选股智能写手 · 05-04
  Morphosys2024财年第一财季实现净利润-3.38亿美元，同比减少609.04%
- 大公司日报|万科再发声，管理层将增持！郁亮：股价距要求很远
  腾讯自选股 · 04-30
  大公司日报|万科再发声，管理层将增持！郁亮：股价距要求很远
- 【消息称三星计划量产的1c DRAM使用MOR光刻胶】金十数据4月30日讯，三星正在考虑在其下一代DRAM极紫外（EUV）光刻工艺中应用金属氧化物抗蚀剂（MOR）。
  美港电讯 · 04-30
  【消息称三星计划量产的1c DRAM使用MOR光刻胶】金十数据4月30日讯，三星正在考虑在其下一代DRAM极紫外（EUV）光刻工艺中应用金属氧化物抗蚀剂（MOR）。
- Morphosys盘中异动股价大跌5.02%
  自选股智能写手 · 04-30
  Morphosys盘中异动股价大跌5.02%
- 受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
  智通财经 · 04-29
  受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行
- 【受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行】智通财经APP获悉，周一，德国生物技术公司Morphosys(MOR.
  智通财经 · 04-29
  【受药物安全问题报道冲击，Morphosys(MOR.US)称诺华制药(NVS.US)收购仍将按计划进行】智通财经APP获悉，周一，德国生物技术公司Morphosys(MOR.
- 【诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约收购价68欧元/股】智通财经APP获悉，诺华制药(NVS.
  智通财经 · 04-11
  【诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约收购价68欧元/股】智通财经APP获悉，诺华制药(NVS.
- 诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约收购价68欧元/股
  智通财经网 · 04-11
  诺华制药(NVS.US)对MorphoSys(MOR.US)发起收购要约收购价68欧元/股
公司概况
公司名称
Morphosys AG
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.morphosys.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
MorphoSys AG成立于1998年3月3日，是一家后期生物制药公司，致力于为患有严重疾病的患者开发创新和差异化疗法。基于其在治疗性抗体发现，发电和工程领域的专有技术平台和领先地位，该公司与其合作伙伴一起参与了100多种治疗性产品的开发。他们广泛的管线跨越两个业务部分：专有开发以及合作发现，该公司根据合作伙伴确定的目标为其制药和生物技术行业的合作伙伴生成候选产品。该公司目前在临床开发中有28种产品候选产品，包括最先进的专利产品候选产品MOR208，用于治疗复发或难治性弥漫大B细胞淋巴瘤。
- 08-16
  超过5%披露
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
  Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
- 07-25
  自愿退市
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
  Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
- 06-21
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 06-18
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 06-10
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 05-28
  超过5%披露
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
  Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
- 04-18
  超过5%披露
  Form SC 13D - General statement of acquisition of beneficial ownership
  Form SC 13D - General statement of acquisition of beneficial ownership
- 03-13
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 03-08
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 03-06
  员工持股计划
  Form S-8 - Securities to be offered to employees in employee benefit plans
  Form S-8 - Securities to be offered to employees in employee benefit plans
- 02-14
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-10-26
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-04-28
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2023-03-15
  年度报告
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 2022-10-25
  员工持股计划
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments